Activation and evasion of the antiviral 2′-5′ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA

RNA

Volumn 8, Issue 4, 2002, Pages 512-525

  Han, Jian Qiu ^a   Barton, David J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

dsRNA; Immune evasion; Innate immunity; Interferon; mRNA stability; RNase L; Virus evolution

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA2 INTERFERON; MESSENGER RNA; RIBAVIRIN; RIBONUCLEASE; RIBONUCLEASE L; TETRAMER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA TEMPLATE; ENZYME ACTIVATION; EVOLUTION; GENE MUTATION; GENOTYPE; HELA CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNITY; OPEN READING FRAME; PRIORITY JOURNAL; RNA CLEAVAGE; RNA SEQUENCE; RNA STABILITY; RNA STRUCTURE; RNA TRANSCRIPTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

BASE SEQUENCE; ENDORIBONUCLEASES; ENZYME ACTIVATION; EVOLUTION, MOLECULAR; HEPACIVIRUS; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; RNA, DOUBLE-STRANDED; RNA, MESSENGER; RNA, VIRAL;

HEPATITIS C VIRUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0036233219     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355838202020617     Document Type: Article

References (61)

1. Complete replication of poliovirus in vitro: Preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA
2. Coupled translation and replication of poliovirus RNA in vitro: Synthesis of functional 3D polymerase and infectious virus
3. Assays for poliovirus polymerase, 3D(Pol), and authentic RNA replication in HeLa S10 extracts
4. cDNA cloning and expression analysis of the murine ribonuclease L inhibitor
5. Secondary structure determination of the conserved 98-base sequence at the 3′ terminus of hepatitis C virus genome RNA
6. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs
7. Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver
8. Chronic hepatitis C: Retreatment of relapsers. An evidence-based approach
9. Activation of RNase L by 2′,5′-oligoadenylates. Kinetic characterization
10. Activation of RNase L by 2′,5′-oligoadenylates. Biophysical characterization
11. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
12. Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies
13. Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA
14. Effects of varying lengths of double-stranded RNA on binding and activation of 2′-5′-oligoadenylate synthetase
15. Genotype distribution of hepatitis C virus infection in Greece: Correlation with different risk factors and response to interferon therapy
16. A bipartite model of 2-5A-dependent RNase L
17. Comparison of fulllength sequences of interferon-sensitive and resistant hepatitis C virus 1b
18. Clinical relevance of hepatitis C virus quasispecies
19. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
20. Interferon action: RNA cleavage pattern of a (2′-5′)oligoadenylate-dependent endonuclease
21. Quasispecies in viral persistence and pathogenesis of hepatitis C virus
22. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
23. Activation of 2′-5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers
24. The human 2′,5′-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms
25. Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C
26. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
27. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA
28. Evading the interferon response: Hepatitis C virus and the interferon-induced protein kinase, PKR
29. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection
30. Mutations in hepatitis C virus RNAs conferring cell culture adaptation
31. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes
32. The RNase L inhibitor (RLI) is induced by double-stranded RNA
33. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure
34. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
35. Cytoplasmically anchored plakoglobin induces a WNT-like phenotype in Xenopus
36. Fractionation and characterization of 2′,5′-oligoadenylates by polyacrylamide gel electrophoresis: An alternative method for assaying 2′,5′-oligoadenylate synthetase
37. Cell-free, de novo synthesis of poliovirus
38. Codon usage tabulated from international DNA sequence databases: Status for the year 2000
39. Double-stranded RNA causes synthesis of 2′,5′-oligo(A) and degradation of messenger RNA in interferon-treated cells
40. Presence of 2′,5′-oligo(A) and of enzymes that synthesize, bind, and degrade 2′,5′-oligo(A) in HeLa cell nuclei
41. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs
42. The 2-5A system: Modulation of viral and cellular processes through acceleration of RNA degradation
43. The human 2′,5′-oligoadenylate synthetase family: Interferon-induced proteins with unique enzymatic properties
44. Internal ribosome entry site-mediated translation in hepatitis C virus replication
45. Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene
46. Selection of hepatitis C virus quasispecies during interferon treatment
47. Enzymatic characteristics of recombinant medium isozyme of 2′-5′ oligoadenylate synthetase
48. Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy
49. Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response
50. A novel transcription property of SP6 and T7 RNA polymerases: Dependence on template structure
51. Activation of the interferon-inducible (2′-5′) oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1
52. rRNA cleavage as an index of ppp(A2′p)nA activity in interferontreated encephalomyocarditis virus-infected cells
53. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
54. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism
55. A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA
56. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2′p)nA) in interferon-treated cells
57. Interferon action - Sequence specificity of the ppp(A2′p)nA-dependent ribonuclease
58. Hepatitis C virus: An infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras
59. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity, and response to interferon therapy
60. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferonalpha